April 6, 2015
A new vaccine that improves the immune response to cancer from the use of altered proteins from the patient’s tumor, which is in the experimental phase, has just been discovered by a group of scientists, led by Venezuelan researcher Beatriz Carreño.
The formula could work well for melanoma and cancers of the lung, bladder and colon, according to a study published in the journal Science.
“Cancer vaccines are generally generalized. This is one of the first custom. The generalized ones use normal proteins without alteration, reason why the immune response is not very strong ”, explained the main researcher of the study.
“In our vaccine we have used altered proteins from the tumor patient and proven that they cause a greater reaction in the T cells.” T cells are a type of immune cell whose function is to recognize foreign substances on the surface of other cells and kill them, for which they produce soluble substances that have effects on tumors and cells infected with viruses, highlights the person in charge of the study.
Via Venezolana develops a vaccine against cancer | Technology | 2001.com.ve.
[+] Videos de nuestro canal de YouTube